{
  "trial_id": "NCT03005639",
  "overall_assessment": "likely_ineligible",
  "inclusion": [],
  "exclusion": [
    {
      "criterion": "prior radiotherapy at lymph node basin",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "prior treatment with BRAF inhibitor or MEK inhibitor",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "active infection",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "pregnant, lactating or breast feeding women",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "concomitant malignancies or previous malignancies within the last 5 years",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "history of malabsorption or other condition that would interfere with absorption of vemurafenib or cobimetinib",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "any underlying medical or psychiatric condition, which in the opinion of the Investigator will make the administration of vemurafenib and cobimetinib hazardous",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "unwillingness or inability to comply with study and follow-up procedures",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "St. John's wort or hyperforin (potent cytochrome P450 CYP3A4 enzyme inducer)",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Grapefruit juice (potent cytochrome P450 CYP3A4 enzyme inhibitor)",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has prior radiotherapy at lymph node basin and is taking anti-hypertensive drugs, which may interfere with study treatment.",
  "_meta": {
    "topic_id": "69",
    "trial_id": "NCT03005639",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}